Title : DPP-4 inhibitors in the management of type 2 diabetes: a critical review of head-to-head trials.

Pub. Date : 2012 Apr

PMID : 22197148






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 DPP-4 inhibitors also exert clinically relevant glucose-lowering effects compared with a placebo in patients treated with SU or TZD (of potential interest when metformin is either not tolerated or contraindicated), and as oral triple therapy with a good tolerability profile when added to a metformin-SU or pioglitazone-SU combination. Metformin dipeptidyl peptidase 4 Homo sapiens